letter_id,letter_issue_date,company_name,subject,letter_url,marcs_cms,Year,repeat_company,repeat_marcs
1,12/30/2025,Absolutely Natural,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eu-natural-inc-605871-05202021,605871.0,2025,0,0
2,12/29/2021,"Varigard, LLC",Unapproved New Drug Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/varigard-llc-616757-12292021,616757.0,2021,0,0
3,12/29/2021,Genesis Partnership Company SA,Drug Product/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/genesis-partnership-company-sa-618953-12292021,618953.0,2021,0,0
4,12/28/2023,Woorilife & Health,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/woorilife-health-672936-12282023,672936.0,2023,0,0
5,12/23/2025,Tower Laboratories Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tower-laboratories-ltd-717456-12232025,717456.0,2025,0,0
6,12/21/2023,Botanical Be,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/botanical-be-671066-12212023,671066.0,2023,0,0
7,12/21/2021,"Vasyl Melnyk, M.D.",Bioresearch Monitoring Program/IRB,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/vasyl-melnyk-md-623671-12212021,623671.0,2021,0,0
8,12/20/2023,"Hua Da Trading, Inc.",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hua-da-trading-inc-664359-12202023,664359.0,2023,0,0
9,12/20/2023,"Amazon.com, Inc.",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazoncom-inc-695821-03032025,695821.0,2023,1,0
10,12/19/2025,Unipack LLC,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/unipack-llc-716621-12192025,716621.0,2025,0,0
11,12/19/2025,Agebox Inc.,Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/agebox-inc-718252-12192025,718252.0,2025,0,0
12,12/19/2025,"LiquidCapsule Manufacturing, LLC",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/liquidcapsule-manufacturing-llc-717069-12192025,717069.0,2025,0,0
13,12/19/2024,"Viatris, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/viatris-inc-690897-12192024,690897.0,2024,0,0
14,12/19/2024,"Fagron Compounding Services, LLC dba Fagron Sterile Service",Compounding Pharmacy/Adulterated Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fagron-compounding-services-llc-dba-fagron-sterile-service-698861-12192024,698861.0,2024,0,0
15,12/19/2023,"Jeffrey W. Taub, M.D./Children's Hospital of Michigan",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/jeffrey-w-taub-mdchildrens-hospital-michigan-674545-12192023,674545.0,2023,0,0
16,12/18/2025,"Private Label Skin Care, Inc.",CGMP/OTC/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/biolab-sciences-inc-621465-08232022,621465.0,2025,0,0
17,12/18/2024,"Sombra Cosmetics, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sombra-cosmetics-inc-692322-12182024,692322.0,2024,0,0
18,12/18/2024,Bhargava Phytolab Private Limited,CGMP/Finished Pharmaceutical/API/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bhargava-phytolab-private-limited-691610-12182024,691610.0,2024,0,0
19,12/17/2024,"Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals",Compounding Pharmacy/Adulterated Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/right-value-drug-stores-llc-dba-carie-boyd-pharmaceuticals-694687-12172024,694687.0,2024,0,0
20,12/17/2024,Akron Formulations India Private Limited,CGMP/Finished Pharmaceutical/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/akron-formulations-india-private-limited-693938-12172024,693938.0,2024,0,0
21,12/17/2024,Brands International Corporation,CGMP/Finished Pharmaceutical/Adulterated/Refusal to Allow Inspection,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/brands-international-corporation-689983-12172024,689983.0,2024,0,0
22,12/16/2025,"Guangdong Renhe Guozhuang Biotechnology Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangdong-renhe-guozhuang-biotechnology-co-ltd-719045-12162025,719045.0,2025,0,0
23,12/16/2024,Indoco Remedies Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/indoco-remedies-limited-691594-12162024,691594.0,2024,0,0
24,12/16/2022,"Superior Glove Works, Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/superior-glove-works-ltd-641100-12162022,641100.0,2022,0,0
25,12/15/2023,Patcos Cosmetics Pvt. Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/patcos-cosmetics-pvt-ltd-669465-12152023,669465.0,2023,0,0
26,12/15/2021,Maquiladora Miniara SA de CV,CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maquiladora-miniara-sa-de-cv-609152-12152021,609152.0,2021,0,0
27,12/14/2023,www.trinexpharmacy.com,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwtrinexpharmacycom-671351-12142023,671351.0,2023,0,0
28,12/14/2022,"Adarsh Daswani, M.D.",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/adarsh-daswani-md-648606-12142022,648606.0,2022,0,0
29,12/14/2021,Guangdong Kemei Pharmaceutical Technology Co. Ltd.,CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangdong-kemei-pharmaceutical-technology-co-ltd-612090-12142021,612090.0,2021,0,0
30,12/12/2025,Prime Sports Nutrition,Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/prime-sports-nutrition-719433-12122025,719433.0,2025,0,0
31,12/12/2025,Atomix LLC,Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/atomix-llc-719111-12122025,719111.0,2025,0,0
32,12/12/2025,Musclepower Enterprise Ltd. dba MONSTER KING and GE LABS,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/musclepower-enterprise-ltd-dba-monster-king-and-ge-labs-719339-12122025,719339.0,2025,0,0
33,12/12/2025,Dynamic Health Group dba SARMS AMERICA,Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dynamic-health-group-dba-sarms-america-719257-12122025,719257.0,2025,0,0
34,12/12/2025,TITAN SARMS LLC,Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/titan-sarms-llc-719645-12122025,719645.0,2025,0,0
35,12/12/2025,Pinnacle Professional Research dba Pinnacle Peptides,Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pinnacle-professional-research-dba-pinnacle-peptides-719337-12122025,719337.0,2025,0,0
37,12/12/2023,"Anish S. Shah, M.D./Siyan Clinical Research",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/anish-s-shah-mdsiyan-clinical-research-674073-12122023,674073.0,2023,0,0
38,12/11/2025,"Devalingam Mahalingam, M.D., Ph.D.",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/devalingam-mahalingam-md-phd-721145-12112025,721145.0,2025,0,0
39,12/10/2025,"Medinatura New Mexico, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medinatura-new-mexico-inc-716025-12102025,716025.0,2025,0,0
40,12/10/2024,Veronvy,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/veronvy-694688-12102024,694688.0,2024,0,0
41,12/10/2024,"Prime Vitality, Inc. dba Prime Peptides",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/prime-vitality-inc-dba-prime-peptides-695156-12102024,695156.0,2024,0,0
42,12/10/2024,Swisschems,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/swisschems-695663-12102024,695663.0,2024,0,0
43,12/10/2024,Xcel Research LLC,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/xcel-research-llc-694608-12102024,694608.0,2024,0,0
44,12/10/2024,Summit Research Peptides,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/summit-research-peptides-695607-12102024,695607.0,2024,0,0
45,12/09/2025,Sklar Personal Care Inc.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sklar-personal-care-inc-716656-12092025,716656.0,2025,0,0
46,12/08/2025,"Darmerica, LLC",CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/darmerica-llc-716152-12082025,716152.0,2025,0,0
47,12/08/2022,Nortec Quimica SA,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nortec-quimica-sa-639894-12082022,639894.0,2022,0,0
48,12/07/2023,"Novid Group, Inc.",CGMP/Finished Pharmaceuticals/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/novid-group-inc-672251-12072023,672251.0,2023,0,0
49,12/07/2022,Centrient Pharmaceuticals India Private Limited,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/centrient-pharmaceuticals-india-private-limited-640196-12072022,640196.0,2022,0,0
50,12/07/2021,"Guangzhou Shiruoni Cosmetics Co., Ltd",CGMP/Finished Pharmaceuticals/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangzhou-shiruoni-cosmetics-co-ltd-613170-12072021,613170.0,2021,0,0
52,12/04/2025,3D Imaging Drug Design and Development LLC,CGMP/Positron Emission Tomography (PET) Drugs/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/3d-imaging-drug-design-and-development-llc-716213-12042025,716213.0,2025,0,0
53,12/03/2024,"Han C. Phan, M.D.",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/han-c-phan-md-696989-12032024,696989.0,2024,0,0
54,12/03/2024,"Applied Therapeutics, Inc.",Sponsor,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/applied-therapeutics-inc-696833-12032024,696833.0,2024,0,0
55,12/03/2024,Micro Orgo Chem,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/micro-orgo-chem-686458-12032024,686458.0,2024,0,0
56,12/01/2023,Belmont Eyecare LLC,Finished Pharmaceuticals/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/belmont-eyecare-llc-670186-12012023,670186.0,2023,0,0
57,12/01/2021,"Eagle Energy USA, Inc.",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eagle-energy-usa-inc-617712-12012021,617712.0,2021,0,0
58,12/01/2021,"VitaStik, Inc.",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/vitastik-inc-617713-12012021,617713.0,2021,0,0
59,12/01/2021,"VitaCig, Inc.",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/vitacig-inc-617847-12012021,617847.0,2021,0,0
60,12/01/2021,"NV Nutrition, LLC",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nv-nutrition-llc-617979-12012021,617979.0,2021,0,0
61,12/01/2021,"Vitamin Vape, Inc.",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/vitamin-vape-inc-617787-12012021,617787.0,2021,0,0
62,11/28/2022,AG Hair Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ag-hair-limited-638646-11282022,638646.0,2022,0,0
63,11/24/2025,"CDL Services, Inc. DBA Technichem",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cdl-services-inc-dba-technichem-713877-11242025,713877.0,2025,0,0
64,11/23/2021,"Hubei Kangzheng Pharmaceutical Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hubei-kangzheng-pharmaceutical-co-ltd-616581-11232021,616581.0,2021,0,0
65,11/22/2023,Dr. Berne’s Whole Health Products,CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dr-bernes-whole-health-products-665456-11222023,665456.0,2023,0,0
66,11/22/2022,Glenmark Pharmaceuticals Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glenmark-pharmaceuticals-limited-708270-07112025,708270.0,2022,1,0
67,11/21/2024,Catwalk Cosmetic Laboratories Pty Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/catwalk-cosmetic-laboratories-pty-ltd-693863-11212024,693863.0,2024,0,0
68,11/21/2024,LCC Ltd.,CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lcc-ltd-688576-11212024,688576.0,2024,1,0
69,11/21/2024,"Dr. Brite, LLC",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dr-brite-llc-684466-11212024,684466.0,2024,0,0
70,11/21/2023,Intas Pharmaceuticals Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/intas-pharmaceuticals-limited-662868-11212023,662868.0,2023,1,0
71,11/20/2024,Eurosirel S.P.A,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eurosirel-spa-690733-11202024,690733.0,2024,0,0
72,11/18/2024,"Hangzhou Huiji Biotechnology Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hangzhou-huiji-biotechnology-co-ltd-692844-11182024,692844.0,2024,0,0
73,11/18/2022,"""David M. Lubeck, M.D./Arbor Centers for EyeCare",Clinical Investigator (Sponsor) ,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/david-m-lubeck-mdarbor-centers-eyecare-643531-11182022,643531.0,2022,0,0
74,11/17/2025,Mahita LLC dba PushMyCart,Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mahita-llc-dba-pushmycart-616541-08192021,616541.0,2025,0,0
75,11/17/2025,"Handelnine Global, LLC dba Navafresh",Unapproved New Drugs/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/handelnine-global-llc-dba-navafresh-716013-11172025,716013.0,2025,0,0
76,11/17/2025,Swift Digital Group LLC dba Swadesii,Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/swift-digital-group-llc-dba-swadesii-716644-11172025,716644.0,2025,0,0
77,11/17/2025,VarunKart Group LLC dba Organic Wellnesses,Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/varunkart-group-llc-dba-organic-wellnesses-716154-11172025,716154.0,2025,0,0
78,11/17/2025,Distacart Inc.,Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/distacart-inc-716212-11172025,716212.0,2025,0,0
79,11/17/2023,AmLion Toothpaste Mfg. Sdn. Bhd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amlion-toothpaste-mfg-sdn-bhd-665879-11172023,665879.0,2023,0,0
80,11/17/2023,Cipla Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-597511-02252020,597511.0,2023,0,0
81,11/17/2023,"Nantong Furuida Packaging Products Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nantong-furuida-packaging-products-co-ltd-667984-11172023,667984.0,2023,0,0
83,11/16/2023,Cerci Kozmetik Ve Otel Ekipmanlari Pazarlama Ic Ve Dis Ticaret Limited Sirketi,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cerci-kozmetik-ve-otel-ekipmanlari-pazarlama-ic-ve-dis-ticaret-limited-sirketi-669488-11162023,669488.0,2023,0,0
84,11/15/2024,Centura Pharmaceuticals Inc,Finished Pharmaceuticals/Unapproved New Drug/Misbranded/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/centura-pharmaceuticals-inc-684733-11152024,684733.0,2024,0,0
85,11/15/2023,"Xiamen Wally Bath Manufacture Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/xiamen-wally-bath-manufacture-co-ltd-669407-11152023,669407.0,2023,0,0
86,11/14/2022,yourtramadol.com,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/yourtramadolcom-639959-11142022,639959.0,2022,0,0
87,11/14/2022,goodimmuno.com,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/goodimmunocom-642697-11142022,642697.0,2022,0,0
88,11/13/2025,123Herbals,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/123herbals-719198-11132025,719198.0,2025,0,0
89,11/13/2025,Cdymax India Pharma Private Limited,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cdymax-india-pharma-private-limited-715022-11132025,715022.0,2025,0,0
90,11/13/2025,Shoplet,Nonprescription/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/shoplet-717846-11132025,717846.0,2025,0,0
92,11/13/2025,Medical Mega,Nonprescription/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medical-mega-717840-11132025,717840.0,2025,0,0
93,11/13/2024,"Guangzhou Four E’s Scientific Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangzhou-four-es-scientific-co-ltd-692061-11132024,692061.0,2024,0,0
94,11/13/2023,Sudesan Temizlik Urunleri Ve Ambalaj Sanaryi Ticaret Anomin Sirketi,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sudesan-temizlik-urunleri-ve-ambalaj-sanaryi-ticaret-anomin-sirketi-666900-11132023,666900.0,2023,0,0
95,11/13/2023,"Amazon.com, Inc.",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazoncom-inc-662503-12202023,662503.0,2023,1,0
96,11/12/2025,"Sinsin Pharmaceutical Co., Ltd.",Nonprescription/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sinsin-pharmaceutical-co-ltd-718720-11122025,718720.0,2025,0,0
97,11/12/2025,Rhyz Analytical Labs,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/rhyz-analytical-labs-715298-11122025,715298.0,2025,0,0
98,11/12/2025,DeVere Manufacturing Inc.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/devere-manufacturing-inc-715846-11122025,715846.0,2025,0,0
100,11/10/2025,"Verdure Sciences, Inc.",Sponsor/Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/verdure-sciences-inc-717259-11102025,717259.0,2025,0,0
101,11/08/2023,"Melanie M. Hoppers, M.D./Physicians Quality Care",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/melanie-m-hoppers-mdphysicians-quality-care-671684-11082023,671684.0,2023,0,0
102,11/08/2023,www.directpharmashop.net,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwdirectpharmashopnet-668345-11082023,668345.0,2023,0,0
103,11/07/2025,"Wells Pharma of Houston, LLC",Compounding Pharmacy/Adulterated Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wells-pharma-houston-llc-713015-11072025,713015.0,2025,0,0
104,11/07/2024,"Zhejiang Qimei Cosmetics Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zhejiang-qimei-cosmetics-co-ltd-690950-11072024,690950.0,2024,0,0
105,11/07/2024,Originitalia SRL,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/originitalia-srl-687935-11072024,687935.0,2024,0,0
106,11/06/2024,"Unexo Lifesciences, Private Limited",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/unexo-lifesciences-private-limited-688163-11062024,688163.0,2024,0,0
107,11/06/2024,"Richard W. Foltin, Ph.D.",Clinical Investigator (Sponsor),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/richard-w-foltin-phd-690189-11062024,690189.0,2024,0,0
108,11/06/2023,Saruhan Kimya Ve Temizlik Urunleri Sanayi Ticaret Anonim Sirketi Corlu Subesi,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/saruhan-kimya-ve-temizlik-urunleri-sanayi-ticaret-anonim-sirketi-corlu-subesi-669487-11062023,669487.0,2023,0,0
109,11/05/2024,Multaler et Cie SAS,CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/multaler-et-cie-sas-685009-11052024,685009.0,2024,0,0
110,11/05/2024,"Colgate-Palmolive/Tom's of Maine, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/colgate-palmolivetoms-maine-inc-687043-11052024,687043.0,2024,0,0
111,11/04/2025,"Siddha Flower Essences, LLC., dba Siddha Remedies",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/siddha-flower-essences-llc-dba-siddha-remedies-713217-11042025,713217.0,2025,0,0
113,11/03/2025,AceCosm,Unapproved New Drugs/Misbranded/Botox Blitz,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/acecosm-718610-11032025,718610.0,2025,0,0
114,11/03/2025,"Dermax Co., Ltd",Unapproved New Drugs/Misbranded/Botox Blitz,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dermax-co-ltd-718712-11032025,718712.0,2025,0,0
115,11/03/2025,Glow Nest Beauty,Unapproved New Drugs/Misbranded/Botox Blitz,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glow-nest-beauty-718710-11032025,718710.0,2025,0,0
116,11/03/2025,Aesthetic Essentials Limited,Unapproved New Drugs/Misbranded/Botox Blitz,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aesthetic-essentials-limited-718707-11032025,718707.0,2025,0,0
117,11/03/2025,Cosmenic,Unapproved New Drugs/Misbranded Botox,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cosmenic-718621-11032025,718621.0,2025,0,0
118,11/03/2025,Elle Pharm,Unapproved New Drugs/Misbranded/Botox Blitz,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/elle-pharm-718713-11032025,718713.0,2025,0,0
119,11/03/2025,Dermacare dba Filler Outlet,Unapproved New Drugs/Misbranded Botox,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dermacare-dba-filler-outlet-718715-11032025,718715.0,2025,0,0
120,11/03/2025,Maypharm,Unapproved New Drugs/Misbranded Botox,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maypharm-718717-11032025,718717.0,2025,0,0
121,11/03/2025,Estaderma,Unapproved New Drugs/Misbranded Botox,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/estaderma-718714-11032025,718714.0,2025,0,0
123,11/03/2025,CelestaPro,Unapproved New Drugs/Misbranded Botox,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/celestapro-718613-11032025,718613.0,2025,0,0
124,11/03/2025,COSMO KOREA,Unapproved New Drugs/Misbranded/Botox,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cosmo-bio-co-ltd-611552-01062022,611552.0,2025,0,0
130,11/03/2025,"Miers Laboratories, Ltd",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/miers-laboratories-ltd-715378-11032025,715378.0,2025,0,0
131,11/03/2022,"The Anthos Group, Inc.",Refusal to Provide Access to and Copying of Records,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/anthos-group-inc-636846-11032022,636846.0,2022,0,0
133,10/31/2025,Apotex Inc.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/apotex-inc-714137-10312025,714137.0,2025,0,0
134,10/31/2022,Abraxis Bioscience LLC,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/abraxis-bioscience-llc-633713-10312022,633713.0,2022,0,0
136,10/30/2024,"Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tianjin-darentang-jingwanhong-pharmaceutical-co-ltd-683619-10302024,683619.0,2024,0,0
137,10/30/2023,"Dexterity Health, LLC DBA Zazzee Naturals",Finished Pharmaceuticals/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dexterity-health-llc-dba-zazzee-naturals-667898-10302023,667898.0,2023,0,0
138,10/29/2025,World Perfumes Inc.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/world-perfumes-inc-713958-10292025,713958.0,2025,0,0
139,10/29/2024,Armstrong County Memorial Hospital,Institutional Review Board (IRB),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/armstrong-county-memorial-hospital-692080-10292024,692080.0,2024,0,0
140,10/28/2022,"Amazon.com, Inc.",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazoncom-inc-662503-12202023,662503.0,2022,1,0
141,10/28/2022,Latin Foods Market,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/latin-foods-market-631753-10282022,631753.0,2022,0,0
142,10/28/2022,Walmart Inc.,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/walmart-inc-720400-12122025,720400.0,2022,0,0
143,10/27/2025,IBSPOT.com Inc.,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ibspotcom-inc-715657-10272025,715657.0,2025,0,0
144,10/27/2025,"DermaRite Industries, LLC",Nonprescription/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dermarite-industries-llc-710997-10272025,710997.0,2025,0,0
145,10/24/2024,Fancy Drops Beauty LLC,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fancy-drops-beauty-llc-688469-10242024,688469.0,2024,0,0
146,10/24/2022,Lakpura LLC,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lakpura-llc-643057-10242022,643057.0,2022,0,0
147,10/23/2024,MedOffice Saglik Endustri Anonim Sirketi,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medoffice-saglik-endustri-anonim-sirketi-687586-10232024,687586.0,2024,0,0
148,10/22/2021,"DongBang Cosmetics Co., Ltd.",CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dongbang-cosmetics-co-ltd-610364-10222021,610364.0,2021,0,0
149,10/21/2025,"Uriel Pharmacy, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/uriel-pharmacy-inc-709977-10212025,709977.0,2025,0,0
150,10/21/2024,"Choice All Natural, Inc. dba Om Botanical",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/choice-all-natural-inc-dba-om-botanical-685615-10212024,685615.0,2024,0,0
151,10/20/2023,Global Pharma Healthcare Private Limited,CGMP/Finished Pharmaceuticals/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/delsam-pharma-llc-657340-02132024,657340.0,2023,0,0
153,10/20/2023,"Maria W. Greenwald, M.D.",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maria-w-greenwald-md-670580-10202023,670580.0,2023,0,0
154,10/19/2022,RiteAid Corporation,Failure to Comply with Drug Listing Requirements/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/riteaid-corporation-643207-10192022,643207.0,2022,0,0
155,10/17/2025,Liebel-Flarsheim Company LLC,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/liebel-flarsheim-company-llc-711508-10172025,711508.0,2025,0,0
156,10/17/2024,Diora Kimya Sanayi ve Ticaret Limited Sirketi,CGMP/Finished Pharmaceuticals/Adulterated/Misbranded/Failure to Register,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/diora-kimya-sanayi-ve-ticaret-limited-sirketi-688271-10172024,688271.0,2024,0,0
157,10/17/2022,"Unit Dose Services, LLC",Failure to Comply with Drug Listing Requirements,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/unit-dose-services-llc-636177-10172022,636177.0,2022,0,0
158,10/16/2025,The Tranzonic Companies/Innocore Sales & Marketing Inc.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tranzonic-companiesinnocore-sales-marketing-inc-712258-10162025,712258.0,2025,0,0
159,10/16/2023,Sun Pharmaceutical Industries Ltd.,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sun-pharmaceutical-industries-limited-677337-06182024,677337.0,2023,0,0
160,10/15/2025,onlineotcmeds.com,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/onlineotcmedscom-717697-10152025,717697.0,2025,0,0
161,10/14/2021,"New Green Nutrition, Inc.",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/new-green-nutrition-inc-615846-10142021,615846.0,2021,0,0
162,10/14/2021,"Joseph A. Zadra, M.D.",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/joseph-zadra-md-619451-10142021,619451.0,2021,0,0
163,10/10/2025,Acme United Corporation,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/acme-united-corporation-712324-10102025,712324.0,2025,0,0
164,10/10/2025,"Foshan Yiying Hygiene Products Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/foshan-yiying-hygiene-products-co-ltd-715548-10102025,715548.0,2025,0,0
165,10/10/2025,"Scientific Protein Laboratories, LLC",CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sethi-laboratories-611628-04062021,611628.0,2025,0,0
166,10/10/2025,"RNA Bio/Pharma, Incorporated",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/rna-biopharma-incorporated-713201-10102025,713201.0,2025,0,0
168,10/10/2024,Soliteint Kozmetikai KFT,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/soliteint-kozmetikai-kft-685146-10102024,685146.0,2024,0,0
169,10/10/2024,"Analytical Food Laboratories, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/analytical-food-laboratories-inc-687513-10102024,687513.0,2024,0,0
170,10/09/2025,Melcare Biomedical Pty Ltd,Nonprescription/OTC.”,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/melcare-biomedical-pty-ltd-717968-10092025,717968.0,2025,0,0
171,10/09/2025,"Taizhou Kangping Medical Science and Technology Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/taizhou-kangping-medical-science-and-technology-co-ltd-711081-10092025,711081.0,2025,0,0
172,10/08/2021,"AriBio H&B Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aribio-hb-co-ltd-613107-10082021,613107.0,2021,0,0
173,10/07/2024,"Hangzhou Glamcos Biotech Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hangzhou-glamcos-biotech-co-ltd-692583-10072024,692583.0,2024,0,0
175,10/06/2025,www.usmedschoice.com,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwusmedschoicecom-716055-10062025,716055.0,2025,0,0
176,10/05/2022,Eksa Mills S.A. de C.V.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eksa-mills-sa-de-cv-634706-10052022,634706.0,2022,0,0
178,10/04/2023,"Handock Cosmetics Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated/Misbranded/Failure to Register/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/handock-cosmetics-co-ltd-658737-10042023,658737.0,2023,0,0
179,10/02/2024,Omni Lens Pvt. Ltd.,CGMP/Finished Pharmaceuticals/Adulterated/Misbranded/Failure to Register,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/omni-lens-pvt-ltd-688151-10022024,688151.0,2024,0,0
180,10/02/2023,"Seoul Cosmetics Co., Ltd.",CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/seoul-cosmetics-co-ltd-653882-10022023,653882.0,2023,0,0
181,10/02/2023,www.semaspace.com,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwsemaspacecom-665848-10022023,665848.0,2023,0,0
182,10/02/2023,www.gorillahealing.com,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwgorillahealingcom-664245-10022023,664245.0,2023,0,0
183,09/30/2025,Guangxi Yulin Pharmaceutical Group Co. Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangxi-yulin-pharmaceutical-group-co-ltd-710422-09302025,710422.0,2025,0,0
184,09/30/2024,Mexicanrxpharm.com,Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mexicanrxpharmcom-693163-09302024,693163.0,2024,0,0
185,09/30/2021,"GuangZhou YouXing Cosmetic Co., Ltd",CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangzhou-youxing-cosmetic-co-ltd-610709-09302021,610709.0,2021,0,0
186,09/30/2021,"RAAS Nutritionals, LLC/Rare Antibody Antigen Supply, Inc.",Bioresearch Monitoring Program/IRB,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/raas-nutritionals-llcrare-antibody-antigen-supply-inc-616560-09302021,616560.0,2021,0,0
187,09/30/2021,"Limpo Quimicos, SA de CV",CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/limpo-quimicos-sa-de-cv-608859-09302021,608859.0,2021,0,0
188,09/29/2023,www.alphamedstore.com,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwalphamedstorecom-665889-09292023,665889.0,2023,0,0
189,09/29/2021,HealthMEDS Inc.,Failure to permit access to or copying of records,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/healthmeds-inc-618484-09292021,618484.0,2021,0,0
190,09/29/2021,Healthy Foods & Nutrition Lab de Mexico S.A. de C.V.,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/healthy-foods-nutrition-lab-de-mexico-sa-de-cv-609608-09292021,609608.0,2021,0,0
191,09/29/2021,"True Chemical Solutions, LLC",Failure to Permit Access to or Copying of Records,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/true-chemical-solutions-llc-616672-09292021,616672.0,2021,0,0
192,09/28/2022,Bespoke Apothecary LLC,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bespoke-apothecary-llc-641573-09282022,641573.0,2022,0,0
193,09/28/2021,"Strategia Project Management, Inc.",Unapproved New Drug Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/strategia-project-management-inc-615307-09282021,615307.0,2021,0,0
194,09/27/2024,Louisiana State University Health Science Center IRB,Institutional Review Board (IRB),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/louisiana-state-university-health-science-center-irb-686088-09272024,686088.0,2024,0,0
195,09/27/2022,Lupin Limited,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lupin-limited-633703-09272022,633703.0,2022,0,0
196,09/26/2024,"Supercore Products Group, Inc.",CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/supercore-products-group-inc-690510-09262024,690510.0,2024,0,0
197,09/26/2024,Makra Kozmetika D.O.O.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/makra-kozmetika-doo-684125-09262024,684125.0,2024,0,0
198,09/26/2023,"Antonio E. Blanco, M.D./Vista Health Research, LLC",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/antonio-e-blanco-mdvista-health-research-llc-668519-09262023,668519.0,2023,0,0
199,09/25/2025,Naturich Cosmetique Labs,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/naturich-cosmetique-labs-713565-09252025,713565.0,2025,0,0
200,09/25/2025,"Creative Essences, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/creative-essences-inc-710658-09252025,710658.0,2025,0,0
201,09/25/2024,Outin Futures Corp.,CGMP/Finished Pharmaceuticals/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/outin-futures-corp-684688-09252024,684688.0,2024,0,0
202,09/25/2023,Shot of Joy LLC,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/shot-joy-llc-665936-09252023,665936.0,2023,0,0
203,09/24/2024,MMC Healthcare Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mmc-healthcare-ltd-684644-09242024,684644.0,2024,0,0
204,09/23/2025,"Persōn & Covey, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/person-covey-inc-711191-09232025,711191.0,2025,0,0
205,09/22/2025,Kath Khemicals LLC,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kath-khemicals-llc-711699-09222025,711699.0,2025,0,0
207,09/22/2021,Ardil Comercial S.R.L.,CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ardil-comercial-srl-612018-09222021,612018.0,2021,0,0
208,09/20/2024,"Azurity Pharmaceuticals, Inc.",CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/azurity-pharmaceuticals-inc-656489-09202024,656489.0,2024,0,0
209,09/20/2023,"Luis Javier Pena-Hernandez, M.D., FCCP",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/luis-javier-pena-hernandez-md-fccp-668217-09202023,668217.0,2023,0,0
210,09/19/2025,"Pamela K. Den Besten, DDS, MS",Clinical Investigator (Sponsor) ,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pamela-k-den-besten-dds-ms-715245-09192025,715245.0,2025,0,0
211,09/19/2023,"Hygienic Labs, LLC",Refusal to Provide Access to and Copying of Records,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hygienic-labs-llc-667816-09192023,667816.0,2023,0,0
212,09/18/2023,Zhao Qing Longda Biotechnology Co. Ltd.,Refusal to Provide Access to and Copying of Records,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zhao-qing-longda-biotechnology-co-ltd-664934-09182023,664934.0,2023,0,0
213,09/17/2025,Dixon Investments Inc. dba ARI,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dixon-investments-inc-dba-ari-710087-09172025,710087.0,2025,0,0
214,09/17/2025,"BRS Analytical Services, LLC",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/brs-analytical-services-llc-711133-09172025,711133.0,2025,0,0
216,09/16/2025,"Stellalife, Inc.",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/stellalife-inc-712804-09162025,712804.0,2025,0,0
217,09/16/2025,Media Networks Sydney Pty. Limited,Failure to Comply with Drug Listing Requirements/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/media-networks-sydney-pty-limited-687044-08152024,687044.0,2025,0,0
218,09/16/2025,Turbare Manufacturing,Compounding Pharmacy/Adulterated Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/turbare-manufacturing-713516-09162025,713516.0,2025,0,0
219,09/15/2021,Laboratorio Pharma International SRL,CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/laboratorio-pharma-international-srl-614766-09152021,614766.0,2021,0,0
220,09/15/2021,"Nanomateriales Químicos Avanzados, S.A. de C.V.",CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nanomateriales-quimicos-avanzados-sa-de-cv-609969-09152021,609969.0,2021,0,0
221,09/14/2023,Maison Blanche LLC,Refusal to Provide Access to and Copying of Records,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maison-blanche-llc-666943-09142023,666943.0,2023,0,0
222,09/13/2021,Furley Bioextracts SDN BHD,CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/furley-bioextracts-sdn-bhd-614592-09132021,614592.0,2021,0,0
223,09/12/2024,Nomida.biz,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nomidabiz-687590-09122024,687590.0,2024,0,0
224,09/12/2023,"Gulf States International, Inc.",Refusal to Provide Access to and Copying of Records,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/gulf-states-international-inc-666918-09122023,666918.0,2023,0,0
225,09/12/2023,Walgreen Company,Failure to Register and List,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/walgreen-company-662158-12192025,662158.0,2023,0,0
226,09/11/2025,Columbia Cosmetics Manufacturing Inc.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/king-systems-corp-dba-ambu-inc-661617-08162023,661617.0,2025,0,0
227,09/11/2025,"Chengdu Brilliant Biopharmaceutical Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/chengdu-brilliant-biopharmaceutical-co-ltd-711330-09112025,711330.0,2025,0,0
228,09/11/2024,"Quality CDMO, Inc.",Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/quality-cdmo-inc-665961-09112024,665961.0,2024,0,0
229,09/11/2023,"Boiron, Inc.",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/boiron-inc-663402-09112023,663402.0,2023,0,0
230,09/11/2023,"Natural Ophthalmics, Inc.",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/natural-ophthalmics-inc-663758-09112023,663758.0,2023,0,0
232,09/11/2023,CVS Health,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cvs-health-663246-09112023,663246.0,2023,0,0
233,09/11/2023,Similasan AG,CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/similasan-ag-658878-09112023,658878.0,2023,0,0
234,09/11/2023,"TRP Company, Inc",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/trp-company-inc-663037-09112023,663037.0,2023,0,0
235,09/11/2023,OcluMed LLC,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/oclumed-llc-663525-09112023,663525.0,2023,0,0
236,09/11/2023,"Walgreens Boots Alliance, Inc.",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/walgreens-boots-alliance-inc-663404-09112023,663404.0,2023,0,0
237,09/10/2025,motionpharmacy.com,Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/motionpharmacycom-715595-09102025,715595.0,2025,0,0
238,09/10/2024,Aromas Para El Alma S.A.,CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aromas-para-el-alma-sa-672728-09102024,672728.0,2024,0,0
239,09/09/2025,Novo Nordisk Inc.,False & Misleading Claims/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/novo-nordisk-inc-716495-09092025,716495.0,2025,0,0
240,09/09/2025,Aytu Biopharma,False & Misleading Claims/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aytu-biopharma-716604-09092025,716604.0,2025,1,0
241,09/09/2025,Aytu Biopharma,False & Misleading Claims/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aytu-biopharma-716604-09092025,716604.0,2025,1,0
242,09/09/2025,"Yangzhou Yulou Paper Products Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/yangzhou-yulou-paper-products-co-ltd-710907-09092025,710907.0,2025,0,0
243,09/09/2025,inspire.clinic,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/paradigm-re-llc-612014-12072020,612014.0,2025,0,0
245,09/09/2025,Eli Lilly and Company,False & Misleading Claims/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716485-09092025,716485.0,2025,1,0
246,09/09/2025,Eli Lilly and Company,False & Misleading Claims/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716485-09092025,716485.0,2025,1,0
247,09/09/2025,Eli Lilly and Company,False & Misleading Claims/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eli-lilly-and-company-716485-09092025,716485.0,2025,1,0
256,09/09/2025,Amazing Meds,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hope-botanicals-llc-623509-05262022,623509.0,2025,0,0
268,09/09/2025,EvoLife Wellness,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/evolife-wellness-715507-09092025,715507.0,2025,0,0
269,09/09/2025,eDrugstore,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/edrugstore-716505-09092025,716505.0,2025,0,0
277,09/09/2025,GLP-1 Solution,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nomidabiz-687590-09122024,687590.0,2025,0,0
281,09/09/2025,All American Wellness,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/new-york-nutrition-company-621839-05042022,621839.0,2025,0,0
284,09/09/2025,Invigorate Med Spa,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/invigorate-med-spa-715872-09092025,715872.0,2025,0,0
286,09/09/2025,Remedy Meds,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medical-chemical-corporation-706007-07092025,706007.0,2025,0,0
290,09/09/2025,Alora Pharmaceuticals,False & Misleading Claims/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/alora-pharmaceuticals-716591-09092025,716591.0,2025,0,0
291,09/09/2025,Elite Health Center,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/elite-vapes-698468-12182024,698468.0,2025,0,0
299,09/09/2025,Master Pharmaceuticals Group,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/master-pharmaceuticals-group-715800-09092025,715800.0,2025,0,0
303,09/09/2025,"Get.Fit.Medical, LLC dba Get.Fit.Medical",Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/curexa-east-llc-dba-curexa-663403-09132023,663403.0,2025,0,0
304,09/09/2025,"FWD Care, Inc. dba FWD",Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fwd-care-inc-dba-fwd-716696-09092025,716696.0,2025,0,0
305,09/09/2024,EnviroServe Chemicals & Cleaners Ltd.,CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/enviroserve-chemicals-cleaners-ltd-674090-09092024,674090.0,2024,0,0
306,09/09/2022,System Kosmetik Produktionsgesellschaft fur kosmetische Gmbh,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/system-kosmetik-produktionsgesellschaft-fur-kosmetische-gmbh-632727-09092022,632727.0,2022,0,0
307,09/08/2025,PureRawz,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/purerawz-715218-09082025,715218.0,2025,0,0
308,09/07/2021,"McDaniel Water, LLC",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mcdaniel-life-line-llc-571303-05162019,571303.0,2021,0,0
309,09/04/2025,"Shirish M. Gadgeel, M.D.",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/shirish-m-gadgeel-md-716181-09042025,716181.0,2025,0,0
310,09/04/2025,Somerset Therapeutics Private Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/somerset-therapeutics-private-limited-711340-09042025,711340.0,2025,0,0
311,09/03/2024,Avaria Health & Beauty Corp.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/avaria-health-beauty-corp-685248-09032024,685248.0,2024,1,0
312,08/31/2021,247rxpill.in,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/247rxpillin-615313-08312021,615313.0,2021,0,0
313,08/30/2024,"Root Bioscience Brands, LLC dba Naternal",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/root-bioscience-brands-llc-dba-naternal-673646-08302024,673646.0,2024,0,0
314,08/29/2024,Orean Personal Care Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/orean-personal-care-ltd-682813-08292024,682813.0,2024,0,0
315,08/29/2024,Zydus Lifesciences Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zydus-lifesciences-limited-685224-08292024,685224.0,2024,0,0
316,08/27/2025,"Amneal Pharmaceuticals, LLC",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amneal-pharmaceuticals-llc-709894-08272025,709894.0,2025,0,0
318,08/27/2024,SoloVital,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/solovital-688046-08272024,688046.0,2024,0,0
319,08/27/2024,Everymarket Inc.,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/everymarket-inc-688348-08272024,688348.0,2024,0,0
320,08/26/2021,"Kaleido Biosciences, Inc.",Bioresearch Monitoring Program,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kaleido-biosciences-inc-616026-08262021,616026.0,2021,0,0
321,08/25/2025,Green Vitality dba Gr33n,Unapproved New Drugs/Ophthalmic Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/green-vitality-dba-gr33n-710151-08252025,710151.0,2025,0,0
331,08/20/2025,Hikal Limited,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hikal-limited-709370-08202025,709370.0,2025,0,0
332,08/20/2024,"Julio R. Flamini, M.D./Clinical Integrative Research Center of Atlanta",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/julio-r-flamini-mdclinical-integrative-research-center-atlanta-691123-08202024,691123.0,2024,0,0
333,08/20/2024,"AnuMed International, LLC",Finished Pharmaceutical/Unapproved New Drug/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/anumed-international-llc-674310-08202024,674310.0,2024,0,0
334,08/19/2021,Toyobo Co. Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/toyobo-co-ltd-614177-08192021,614177.0,2021,0,0
335,08/19/2021,"Mahita, LLC dba PushMyCart",Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mahita-llc-dba-pushmycart-616541-08192021,616541.0,2021,0,0
337,08/18/2023,Molluscumaway LLC,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/molluscumaway-llc-650100-08182023,650100.0,2023,0,0
338,08/18/2023,"MolluscumRx, Inc.",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/molluscumrx-inc-648457-08182023,648457.0,2023,0,0
339,08/18/2023,"Nature’s Innovation, Inc.",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/natures-innovation-inc-648560-08182023,648560.0,2023,0,0
341,08/18/2023,"Walmart, Inc",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/walmart-inc-720400-12122025,720400.0,2023,0,0
342,08/17/2022,"Zhejiang Tianyu Pharmaceutical Co., Ltd.",CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zhejiang-tianyu-pharmaceutical-co-ltd-631054-08172022,631054.0,2022,0,0
343,08/16/2022,Tramadol US,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tramadol-us-634444-08162022,634444.0,2022,0,0
344,08/15/2024,Media Networks Sydney Pty Limited,Failure to Register and List,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/media-networks-sydney-pty-limited-687044-08152024,687044.0,2024,0,0
345,08/15/2024,Eugia Pharma Specialities Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eugia-pharma-specialities-limited-681905-08152024,681905.0,2024,0,0
346,08/15/2024,Intercos Europe S.p.A,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/intercos-europe-spa-682273-08152024,682273.0,2024,0,0
347,08/14/2023,"K. Boeun Pharmaceutical Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/k-boeun-pharmaceutical-co-ltd-665099-08142023,665099.0,2023,0,0
348,08/11/2025,"Everlaan Organics, Inc. dba Maple Organics",CGMP/OTC/Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/everlaan-organics-inc-dba-maple-organics-707956-08112025,707956.0,2025,0,0
349,08/11/2025,"Anhui Hanbon Daily Chemical Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/anhui-hanbon-daily-chemical-co-ltd-708903-08112025,708903.0,2025,0,0
350,08/11/2023,Cosmobeauti Laboratories & Manufacturing Inc.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cosmobeauti-laboratories-manufacturing-inc-657682-08112023,657682.0,2023,0,0
351,08/09/2023,CalmCo LLC previously named Ketomi LLC,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/denison-pharmaceuticals-llc-654226-07262023,654226.0,2023,0,0
353,08/08/2023,"Angela M. Stupi, M.D.",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/angela-m-stupi-md-665471-08082023,665471.0,2023,0,0
354,08/07/2023,"Laavo Clean, S.A. de C.V.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/laavo-clean-sa-de-cv-646574-08072023,646574.0,2023,0,0
355,08/06/2025,Vacation Inc.,OTC/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/vacation-inc-706039-08062025,706039.0,2025,0,0
356,08/06/2025,Kalani AB dba Kalani Sunwear,OTC/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kalani-ab-dba-kalani-sunwear-710998-08062025,710998.0,2025,0,0
357,08/06/2025,K & Care Organics,OTC/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/k-care-organics-711000-08062025,711000.0,2025,0,0
358,08/06/2025,Fallien Cosmeceuticals Ltd. dba Fallene Ltd.,OTC/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fallien-cosmeceuticals-ltd-dba-fallene-ltd-711006-08062025,711006.0,2025,0,0
359,08/06/2025,Supergoop!,OTC/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/supergoop-711018-08062025,711018.0,2025,0,0
360,08/04/2023,"Cergomex Imports, LLC",Refusal to Provide Access to and Copying of Records,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cergomex-imports-llc-664362-08042023,664362.0,2023,0,0
361,08/04/2023,GTP International Corp,Refusal to Provide Access to and Copying of Records,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/gtp-international-corp-664367-08042023,664367.0,2023,0,0
362,08/04/2022,FluxxLab LLC,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fluxxlab-llc-637158-08042022,637158.0,2022,0,0
363,08/04/2022,"Amazon.com, Inc.",Finished Pharmaceuticals/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazoncom-inc-662503-12202023,662503.0,2022,1,0
364,08/04/2022,JB Exchange Inc./Justified Laboratories,Finished Pharmaceuticals/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/jb-exchange-incjustified-laboratories-631521-08042022,631521.0,2022,0,0
365,08/04/2022,Ariella Naturals,Finished Pharmaceuticals/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ariella-naturals-632509-08042022,632509.0,2022,0,0
366,08/03/2023,"Fancystage Unipessoal, LDA",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fancystage-unipessoal-lda-678453-06042024,678453.0,2023,1,0
367,08/03/2023,Avaria Health & Beauty Corp.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/avaria-health-beauty-corp-685248-09032024,685248.0,2023,1,0
368,08/03/2023,KM Pharmaceutical Co. Ltd.,Refusal to Provide Access to and Copying of Records,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/km-pharmaceutical-co-ltd-663522-08032023,663522.0,2023,0,0
369,08/03/2023,Tan Alize Kozmetik Ve Temizlik Urunleri,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tan-alize-kozmetik-ve-temizlik-urunleri-659854-08032023,659854.0,2023,0,0
370,08/03/2023,"Sangleaf Pharm., Co. Ltd.",Failure to Provide Information,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sangleaf-pharm-co-ltd-663495-08032023,663495.0,2023,0,0
371,08/03/2023,LCC Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lcc-ltd-657336-08032023,657336.0,2023,1,0
372,08/03/2023,Suhan Aerosol,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/suhan-aerosol-663489-08032023,663489.0,2023,0,0
373,08/03/2023,Skyline Herbals Private Limited,Refusal to Provide Access to and Copying of Records,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/skyline-herbals-private-limited-663659-08032023,663659.0,2023,0,0
374,08/03/2023,Daxal Cosmetics Private Limited,Refusal to Provide Access to and Copying of Records,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/daxal-cosmetics-private-limited-663658-08032023,663658.0,2023,0,0
375,08/03/2023,Orchid Lifesciences,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/orchid-lifesciences-663478-08032023,663478.0,2023,0,0
376,08/01/2025,Confer With,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/confer-707691-08012025,707691.0,2025,0,0
377,08/01/2025,www.usaquickmeds.com,Misbranded and Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwusaquickmedscom-713312-08012025,713312.0,2025,0,0
378,08/01/2024,Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangzhou-baiyunshan-jingxiutang-pharmaceutical-co-ltd-675823-08012024,675823.0,2024,0,0
379,07/29/2025,AlzClipp / UniUni,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/alzclipp-uniuni-711274-07292025,711274.0,2025,0,0
380,07/29/2025,cheaptrustedpharmacy.com,Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cheaptrustedpharmacycom-705501-07292025,705501.0,2025,0,0
381,07/28/2025,Health and Natural Beauty USA Corp.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/avaria-health-beauty-corp-685248-09032024,685248.0,2025,0,0
382,07/28/2023,Intas Pharmaceuticals Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/intas-pharmaceuticals-limited-662868-11212023,662868.0,2023,1,0
383,07/25/2024,"Amazon.com, Inc.",Finished Pharmaceuticals/Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazoncom-inc-662503-12202023,662503.0,2024,1,0
384,07/25/2024,"Walmart, Inc.",Finished Pharmaceuticals/Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/walmart-inc-720400-12122025,720400.0,2024,0,0
385,07/25/2024,ISIS.GOLD,Finished Pharmaceuticals/Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/isisgold-679948-07252024,679948.0,2024,0,0
386,07/25/2024,Skin Beauty Solutions,Finished Pharmaceuticals/Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazoncom-inc-679523-07252024,679523.0,2024,0,0
387,07/25/2024,Repare Skincare,Finished Pharmaceuticals/Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/repare-skincare-680247-07252024,680247.0,2024,0,0
388,07/25/2024,Matte Beauty,Finished Pharmaceuticals/Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/matte-beauty-679463-07252024,679463.0,2024,0,0
389,07/25/2023,Baxter Healthcare Corporation,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/baxter-healthcare-corporation-654136-07252023,654136.0,2023,0,0
390,07/25/2023,Centaur Pharmaceuticals Private Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/centaur-pharmaceuticals-private-ltd-655231-07252023,655231.0,2023,1,0
391,07/23/2025,Shiva Analyticals Private Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/shiva-analyticals-private-limited-707857-07232025,707857.0,2025,0,0
392,07/22/2024,V10Suppliers.com,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/v10supplierscom-685496-07222024,685496.0,2024,0,0
393,07/21/2023,"Gadget Island, Inc.",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/gadget-island-inc-658733-07212023,658733.0,2023,0,0
394,07/21/2022,Jose Miguel Gutierrez Salas,Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated/Failure to Register and List,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/jose-miguel-gutierrez-salas-609983-07212022,609983.0,2022,0,0
395,07/20/2023,Medgel Private Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medgel-private-limited-654085-07202023,654085.0,2023,0,0
396,07/20/2023,Wise Women’s Choice,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wise-womens-choice-658897-07202023,658897.0,2023,0,0
397,07/20/2022,"Guangzhou Orchard Aromatherapy & Skin Care Co., Ltd.",Refusal to Provide Access to and Copying of Records,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangzhou-orchard-aromatherapy-skin-care-co-ltd-628678-07202022,628678.0,2022,0,0
398,07/18/2025,"Janssen Vaccines Corp., A Johnson & Johnson Company",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/janssen-vaccines-corp-johnson-johnson-company-713194-07182025,713194.0,2025,0,0
399,07/18/2025,Kabana Skin Care LLC,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kabana-skin-care-llc-710232-07182025,710232.0,2025,0,0
400,07/17/2025,www.mysteroidsmarket.com,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwmysteroidsmarketcom-711353-07172025,711353.0,2025,0,0
401,07/17/2024,Velocity Pharma LLC,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/velocity-pharma-llc-676434-07172024,676434.0,2024,0,0
402,07/16/2025,www.plakini-pharma.com,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwplakini-pharmacom-705185-07162025,705185.0,2025,0,0
403,07/16/2025,www.d-pharmacy.com,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwd-pharmacycom-711075-07162025,711075.0,2025,0,0
404,07/16/2025,www.portmeds.com,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwportmedscom-711585-07162025,711585.0,2025,0,0
405,07/15/2025,"Oasis Medical, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/oasis-medical-inc-707198-07152025,707198.0,2025,0,0
406,07/14/2022,"Daniel Fred Goodman, M.D./Goodman Eye Center",Bioresearch Monitoring Program/Institutional Review Board (IRB),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/daniel-fred-goodman-mdgoodman-eye-center-634247-07142022,634247.0,2022,0,0
407,07/11/2025,Glenmark Pharmaceuticals Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glenmark-pharmaceuticals-limited-708270-07112025,708270.0,2025,1,0
408,07/11/2024,"Jiangsu Hengrui Pharmaceuticals Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/jiangsu-hengrui-pharmaceuticals-co-ltd-679790-07112024,679790.0,2024,0,0
409,07/11/2024,Brassica Pharma Pvt. Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/brassica-pharma-pvt-ltd-679005-07112024,679005.0,2024,0,0
410,07/11/2024,Nowrez & Ismail Shukri Company,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nowrez-ismail-shukri-company-682810-07112024,682810.0,2024,0,0
411,07/09/2025,Scope Health Inc,Unapproved New Drugs/Misbranded/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/scope-health-inc-695085-07092025,695085.0,2025,0,0
412,07/09/2025,"Thea Pharma, Inc.",Unapproved New Drugs/Misbranded/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/thea-pharma-inc-712416-07092025,712416.0,2025,0,0
413,07/09/2025,"Revitalize Energy, Inc.",Unapproved New Drugs/Misbranded/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/revitalize-energy-inc-712417-07092025,712417.0,2025,0,0
414,07/09/2025,"EyeTech One, LLC",Unapproved New Drugs/Misbranded/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eyetech-one-llc-712438-07092025,712438.0,2025,0,0
415,07/09/2025,Covalent Medical,Unapproved New Drugs/Misbranded/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/covalent-medical-695839-07092025,695839.0,2025,0,0
416,07/09/2025,Medical Chemical Corporation,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medical-chemical-corporation-706007-07092025,706007.0,2025,0,0
417,07/09/2025,Gussyup LLC dba Private Label Grooming,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/gussyup-llc-dba-private-label-grooming-709488-07092025,709488.0,2025,0,0
418,07/09/2024,Cholrem Pty Ltd dba Cholrem and Cholrem Pharmaceuticals,Finished Pharmaceuticals/Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cholrem-pty-ltd-dba-cholrem-and-cholrem-pharmaceuticals-684036-07092024,684036.0,2024,0,0
419,07/08/2024,"YangZhou SuXiang Medical Instrument Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/yangzhou-suxiang-medical-instrument-co-ltd-686655-07082024,686655.0,2024,0,0
420,07/06/2022,Elite Supplement Center LLC and Elite Training Facility LLC,Finished Pharmaceuticals/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/elite-supplement-center-llc-and-elite-training-facility-llc-627498-07062022,627498.0,2022,0,0
421,07/03/2023,"Sunshine Trading Company, Inc. dba Nova Tea and Nova Kratom",Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sunshine-trading-company-inc-dba-nova-tea-and-nova-kratom-660633-07032023,660633.0,2023,0,0
422,07/02/2025,"Exela Pharma Sciences, LLC",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/exela-pharma-sciences-llc-709859-07022025,709859.0,2025,0,0
423,07/02/2025,"Daewoo Pharmaceutical Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/daewoo-pharmaceutical-co-ltd-706371-07022025,706371.0,2025,0,0
424,07/02/2024,"Premier Manufacturing Products, LLC",Finished Pharmaceuticals/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/premier-manufacturing-products-llc-678912-07022024,678912.0,2024,0,0
425,06/30/2022,Herbsens Botanicals,Finished Pharmaceuticals/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/herbsens-botanicals-634373-06302022,634373.0,2022,0,0
426,06/30/2022,Klarity Kratom,Finished Pharmaceuticals/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/klarity-kratom-634501-06302022,634501.0,2022,0,0
427,06/30/2022,Kratom Exchange,Finished Pharmaceuticals/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kratom-exchange-633972-06302022,633972.0,2022,0,0
429,06/30/2022,"MONQ, LLC",Finished Pharmaceuticals/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/monq-llc-613570-06302022,613570.0,2022,0,0
430,06/30/2022,"Bioiberica, SAU",CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bioiberica-sau-629115-06302022,629115.0,2022,0,0
431,06/27/2025,"Libby Laboratories, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/libby-laboratories-inc-708259-06272025,708259.0,2025,0,0
435,06/26/2024,"reBom Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/rebom-co-ltd-682811-06262024,682811.0,2024,0,0
436,06/26/2023,Lydia Co. Ltd.,Failure to Register and List,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lydia-co-ltd-659646-06262023,659646.0,2023,0,0
437,06/25/2025,"Xtreme Tools International, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/xtreme-tools-international-inc-706053-06252025,706053.0,2025,0,0
438,06/25/2025,"7Tabz Retail, LLC",Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/7tabz-retail-llc-709546-06252025,709546.0,2025,0,0
439,06/25/2025,"Hydroxie, LLC",Unapproved New Drug/Human Food/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hydroxie-llc-709661-06252025,709661.0,2025,0,0
440,06/25/2025,Nature’s Fusions LLC,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/natures-fusions-llc-707024-06252025,707024.0,2025,0,0
441,06/24/2024,Ozempen.com,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ozempencom-684435-06242024,684435.0,2024,0,0
442,06/22/2023,Suprimo Imports,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/suprimo-imports-657631-06222023,657631.0,2023,0,0
443,06/22/2022,"Mirfeel Korea Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mirfeel-korea-co-ltd-627401-06222022,627401.0,2022,0,0
444,06/22/2022,Industrias Cklass S. de R.L. de C.V.,Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/industrias-cklass-s-de-rl-de-cv-610275-06222022,610275.0,2022,0,0
445,06/20/2023,"Chengdu KeCheng Fine Chemicals Co., Ltd.",CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/chengdu-kecheng-fine-chemicals-co-ltd-659389-06202023,659389.0,2023,0,0
446,06/18/2025,"Peter Michael, M.D.",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/peter-michael-md-711299-06182025,711299.0,2025,0,0
447,06/18/2025,"Dynamic Blending Specialists, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dynamic-blending-specialists-inc-701278-06182025,701278.0,2025,0,0
448,06/18/2024,Sun Pharmaceutical Industries Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sun-pharmaceutical-industries-limited-677337-06182024,677337.0,2024,0,0
449,06/18/2024,Laboratorio Magnachem International,CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/laboratorio-magnachem-international-673796-06182024,673796.0,2024,0,0
450,06/16/2025,Pushclean Technology Plastik Sanayi Ve Ticaret Ltd. Sirketi,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pushclean-technology-plastik-sanayi-ve-ticaret-ltd-sirketi-709156-06162025,709156.0,2025,0,0
451,06/14/2024,Vegewax Candleworx Ltd.,CGMP/Finished Pharmaceutical/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/vegewax-candleworx-ltd-675099-06142024,675099.0,2024,0,0
452,06/14/2023,"Randy J. Epstein, M.D./Chicago Cornea Consultants, Ltd.",Clinical Investigator (Sponsor) ,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/randy-j-epstein-mdchicago-cornea-consultants-ltd-658917-06142023,658917.0,2023,0,0
453,06/13/2025,www.soma4ever.com,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwsoma4evercom-706082-06132025,706082.0,2025,0,0
454,06/13/2024,"GFA Production Xiamen Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/gfa-production-xiamen-co-ltd-678364-06132024,678364.0,2024,0,0
456,06/12/2025,Kenil Healthcare Private Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kenil-healthcare-private-limited-704786-06122025,704786.0,2025,0,0
457,06/12/2025,www.buynetmeds.com,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwbuynetmedscom-706335-06122025,706335.0,2025,0,0
458,06/12/2025,Healwell Homeo Private Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/healwell-homeo-private-limited-706206-06122025,706206.0,2025,0,0
459,06/12/2024,Landy International,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/landy-international-679066-06122024,679066.0,2024,0,0
460,06/12/2024,"Aqualex Co., Ltd.",CGMP/Finished Pharmaceuticals/Unapproved New Drug/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aqualex-co-ltd-672292-06122024,672292.0,2024,0,0
461,06/12/2023,Warrior Labz SARMS,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/warrior-labz-sarms-655280-06122023,655280.0,2023,0,0
462,06/10/2025,www.buyprosoma.com,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwbuyprosomacom-705973-06102025,705973.0,2025,0,0
463,06/09/2021,Natural Beauty Care Pty Ltd,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/natural-beauty-care-pty-ltd-611974-06092021,611974.0,2021,0,0
464,06/07/2024,"Angela D. Ritter, M.D.",Clinical Investigator (Sponsor),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/angela-d-ritter-md-681999-06072024,681999.0,2024,0,0
465,06/06/2025,Horizon Tool Inc.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/horizon-tool-inc-706567-06062025,706567.0,2025,0,0
466,06/05/2025,Sterling Distributors,Drug Supply Chain Security Act (DSCSA) Violations,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sterling-distributors-706508-06052025,706508.0,2025,0,0
467,06/05/2024,TCT Nutraceuticals SDN. BHD,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tct-nutraceuticals-sdn-bhd-680743-06052024,680743.0,2024,0,0
468,06/05/2024,"Yahon Enterprise Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/yahon-enterprise-co-ltd-675592-06052024,675592.0,2024,0,0
469,06/05/2023,Centaur Pharmaceuticals Private Ltd.,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/centaur-pharmaceuticals-private-ltd-655231-07252023,655231.0,2023,1,0
470,06/04/2025,www.bigpharmausa.com,Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwbigpharmausacom-702681-06042025,702681.0,2025,0,0
471,06/04/2024,"Fancystage Unipessoal, LDA",CGMP/Finished Pharmaceuticals/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fancystage-unipessoal-lda-678453-06042024,678453.0,2024,1,0
472,05/31/2023,"Mobeen Mazhar, M.D.",Investigational Device Exemptions (Clinical Investigator),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mobeen-mazhar-md-660335-05312023,660335.0,2023,0,0
473,05/30/2025,Bio Wellness 444 LLC,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bio-wellness-444-llc-709333-05302025,709333.0,2025,0,0
474,05/29/2025,"Amish Origins Management, LLC",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amish-origins-management-llc-704166-05292025,704166.0,2025,0,0
475,05/29/2025,Laboratoire Druide Inc.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/laboratoire-druide-inc-705517-05292025,705517.0,2025,0,0
476,05/27/2022,"Smitha C. Reddy, M.D./ACRC Studies, LLC",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/smitha-c-reddy-mdacrc-studies-llc-634702-05272022,634702.0,2022,0,0
478,05/22/2023,citypharma.us,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/citypharmaus-657459-05222023,657459.0,2023,0,0
479,05/19/2025,"CTK OTC Laboratories LLC formerly FMK LABS, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ctk-otc-laboratories-llc-formerly-fmk-labs-inc-705479-05192025,705479.0,2025,0,0
480,05/19/2022,"Santhigram Kerala Ayurvedic Co. of U.S., Inc.",Unapproved New Drugs,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/santhigram-kerala-ayurvedic-co-us-inc-625892-05192022,625892.0,2022,0,0
481,05/19/2022,"Ayuryoga, Inc.",Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ayuryoga-inc-628168-05192022,628168.0,2022,0,0
482,05/18/2023,Champaklal Maganlal Homeo Pharmacy Private Limited,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/champaklal-maganlal-homeo-pharmacy-private-limited-652319-04102023,652319.0,2023,1,0
483,05/14/2025,Evi Labs LLC,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/evi-labs-llc-705846-05142025,705846.0,2025,0,0
484,05/14/2025,"Zhejiang Easyclean Daily Chemical Co., Ltd",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zhejiang-easyclean-daily-chemical-co-ltd-702295-05142025,702295.0,2025,0,0
485,05/13/2025,"AACE Pharmaceuticals, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aace-pharmaceuticals-inc-701310-05132025,701310.0,2025,0,0
486,05/13/2024,Aruba Aloe Balm N.V.,CGMP/Finished Pharmaceuticals/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aruba-aloe-balm-nv-674911-05132024,674911.0,2024,0,0
487,05/13/2021,Gulsah Uretim Kozmetik Sanayi Anonim Sirketi,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/gulsah-uretim-kozmetik-sanayi-anonim-sirketi-611591-05132021,611591.0,2021,0,0
488,05/08/2025,Product Society LLC,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/product-society-llc-702927-05082025,702927.0,2025,0,0
489,05/07/2025,Excelvision Fareva,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/excelvision-fareva-703245-05072025,703245.0,2025,0,0
490,05/06/2025,"Shenzhen Hengkaifeng Commerce and Trade Co., Ltd",Failure to List/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/shenzhen-hengkaifeng-commerce-and-trade-co-ltd-706318-05062025,706318.0,2025,0,0
491,05/06/2021,"Lauren R. Klein, MD, M.S.",Failure to obtain Investigational New Drug Applications,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lauren-r-klein-md-ms-605544-05062021,605544.0,2021,0,0
493,05/05/2025,www.peacefulmeds.com,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwpeacefulmedscom-703470-05052025,703470.0,2025,0,0
494,05/05/2025,"Staska Pharmaceuticals, Inc.",Compounding Pharmacy/Adulterated Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/staska-pharmaceuticals-inc-699291-05052025,699291.0,2025,0,0
495,05/05/2021,"Jon B. Cole, MD",Failure to obtain Investigational New Drug Applications,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/jon-b-cole-md-611902-05052021,611902.0,2021,0,0
496,05/04/2022,BioMD Plus LLC,Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/biomd-plus-llc-618460-05042022,618460.0,2022,0,0
497,05/04/2022,"M Six Labs, Inc.",Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/m-six-labs-inc-618701-05042022,618701.0,2022,0,0
498,05/04/2022,Kingdom Harvest,Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kingdom-harvest-625058-05042022,625058.0,2022,0,0
499,05/04/2022,"ATLRx, Inc.",Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/atlrx-inc-618341-05042022,618341.0,2022,0,0
501,05/04/2022,Inhousepharmacy.vu,Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/inhousepharmacyvu-620327-05042022,620327.0,2022,0,0
502,05/03/2024,"Natuzen Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/natuzen-co-ltd-677942-05032024,677942.0,2024,0,0
503,05/02/2024,"Kevin R. Bender, M.D./DBC Research Corporation",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kevin-r-bender-mddbc-research-corporation-680072-05022024,680072.0,2024,0,0
504,05/02/2022,"David Cosmetic Co., Ltd.",CGMP/Finished Pharmaceutical/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/david-cosmetic-co-ltd-627408-05022022,627408.0,2022,0,0
505,04/30/2025,"Ningbo Riway Industrial Co., Ltd.",CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ningbo-riway-industrial-co-ltd-692870-04302025,692870.0,2025,0,0
506,04/30/2025,Rechon Life Science AB,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/rechon-life-science-ab-701040-04302025,701040.0,2025,0,0
507,04/30/2025,"American Behavioral Research Institute, LLC",Clinical Investigator (Sponsor),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/american-behavioral-research-institute-llc-705629-04302025,705629.0,2025,0,0
508,04/30/2024,Ward Smelling Salts,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ward-smelling-salts-672166-04302024,672166.0,2024,0,0
509,04/30/2024,Global Cosmetics Company Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/global-cosmetics-company-limited-677948-04302024,677948.0,2024,0,0
510,04/30/2024,Grupo Quimico SRL,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/grupo-quimico-srl-674010-04302024,674010.0,2024,0,0
511,04/28/2025,"Nana Barseghian, M.D.",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nana-barseghian-md-708009-04282025,708009.0,2025,0,0
512,04/27/2023,"Tager Online, Inc. DBA Volt Candy; Volt Candy Wholesale Club",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tager-online-inc-dba-volt-candy-volt-candy-wholesale-club-652780-04272023,652780.0,2023,0,0
513,04/24/2024,www.dashpct.com,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwdashpctcom-679727-04242024,679727.0,2024,0,0
514,04/24/2023,Nose Slap LLC,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nose-slap-llc-654566-04242023,654566.0,2023,0,0
515,04/23/2025,www.24hreup.biz,Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/www24hreupbiz-700358-04232025,700358.0,2025,0,0
516,04/23/2025,"OSRX, Inc.",Compounding Pharmacy/Adulterated Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/osrx-inc-701889-04232025,701889.0,2025,0,0
517,04/19/2023,Sorcerz.com,Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sorcerzcom-656021-04192023,656021.0,2023,0,0
519,04/19/2022,"Kleenhanz, LLC",Unapproved Drug Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kleenhanz-llc-605499-04192022,605499.0,2022,0,0
520,04/19/2022,"Guangzhou Zhongkebaishi Health Industry Co., Ltd.",Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangzhou-zhongkebaishi-health-industry-co-ltd-613267-04192022,613267.0,2022,0,0
521,04/18/2024,Zen Enterprises LLC,Failure to Register and List,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zen-enterprises-llc-678407-09112024,678407.0,2024,0,0
522,04/18/2024,Dr Sankunni’s Ayurvedic Research Foundation Private Ltd.,Failure to Register and List,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dr-sankunnis-ayurvedic-research-foundation-private-ltd-678046-04182024,678046.0,2024,0,0
523,04/17/2025,"Amazon.com, Inc.",Unapproved New Drugs/Misbranded/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazoncom-inc-629452-08042022,629452.0,2025,1,0
524,04/16/2025,Mentha & Allied Products Private Ltd.,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mentha-allied-products-private-ltd-700242-04162025,700242.0,2025,0,0
525,04/15/2025,"Shantou S.E.Z. Baojie Industry Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/shantou-sez-baojie-industry-co-ltd-703439-04152025,703439.0,2025,0,0
526,04/14/2025,"Cosco International, Inc.",CGMP/Finished Pharmaceuticals/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cosco-international-inc-701209-04142025,701209.0,2025,0,0
528,04/13/2022,"Skin Authority, L.L.C.",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/skin-authority-llc-628385-04132022,628385.0,2022,0,0
529,04/13/2022,AMBI Enterprises LLC,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ambi-enterprises-llc-628367-04132022,628367.0,2022,0,0
530,04/13/2022,"Genomma Lab USA, Inc.",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/genomma-lab-usa-inc-628381-04132022,628381.0,2022,0,0
531,04/13/2022,"M & M Beauty and Wellness, LLC",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/m-m-beauty-and-wellness-llc-628392-04132022,628392.0,2022,0,0
532,04/13/2022,"True Earth Health Products, LLC",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/true-earth-health-products-llc-628383-04132022,628383.0,2022,0,0
533,04/13/2022,Ultimark Products,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ultimark-products-628389-04132022,628389.0,2022,0,0
534,04/13/2022,SkinPro,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/skinpro-628398-04132022,628398.0,2022,0,0
535,04/13/2022,Skin PS Brands,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/skin-ps-brands-628396-04132022,628396.0,2022,0,0
536,04/13/2022,Clinical Formula LLC,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/clinical-formula-llc-628372-04132022,628372.0,2022,0,0
537,04/13/2022,"Neoteric Cosmetics, Incorporated/Scott’s Liquid Gold, Inc.",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/neoteric-cosmetics-incorporatedscotts-liquid-gold-inc-628399-04132022,628399.0,2022,0,0
538,04/13/2022,Dr. Thomas Balshi/Intilight,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dr-thomas-balshiintilight-628402-04132022,628402.0,2022,0,0
539,04/11/2024,"C&T Dream Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ct-dream-co-ltd-678300-04112024,678300.0,2024,0,0
540,04/10/2023,Champaklal Maganlal Homeo Pharmacy Private Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/champaklal-maganlal-homeo-pharmacy-private-limited-652319-04102023,652319.0,2023,1,0
541,04/09/2025,"Dyno Manufacturing, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dyno-manufacturing-inc-700785-04092025,700785.0,2025,0,0
542,04/09/2025,BEO Pharma Inc. dba BEO Pharmaceuticals Inc.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/beo-pharma-inc-dba-beo-pharmaceuticals-inc-701364-04092025,701364.0,2025,0,0
543,04/08/2025,Tailstorm Health Inc. dba Medivant Health,Compounding Pharmacy/Adulterated Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tailstorm-health-inc-dba-medivant-health-703497-04082025,703497.0,2025,0,0
544,04/08/2024,Natco Pharma Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/natco-pharma-limited-672564-04082024,672564.0,2024,0,0
545,04/07/2025,"PMS4PMS, LLC",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pms4pms-llc-700180-04072025,700180.0,2025,0,0
547,04/06/2022,www.wellerectile.com,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwwellerectilecom-615690-04062022,615690.0,2022,0,0
548,04/06/2022,"Sensory Cloud, Inc",Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sensory-cloud-inc-628897-04062022,628897.0,2022,0,0
549,04/05/2022,"""Daniel C. Tarquinio, D.O./Center for Rare Neurological Diseases",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/daniel-c-tarquinio-docenter-rare-neurological-diseases-630976-04052022,630976.0,2022,0,0
550,04/05/2022,"CofixRx, LLC",Unapproved New Drug Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cofixrx-llc-626860-04052022,626860.0,2022,0,0
551,04/04/2025,"Wuxi Medical Instrument Factory Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wuxi-medical-instrument-factory-co-ltd-701044-04042025,701044.0,2025,0,0
552,04/03/2024,Jiangsu Meifan Biotechnology Co. Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/jiangsu-meifan-biotechnology-co-ltd-676562-04032024,676562.0,2024,0,0
553,04/03/2024,"FirstCham Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/firstcham-co-ltd-672903-04032024,672903.0,2024,0,0
554,04/02/2025,"Empower Clinic Services, LLC dba Empower Pharma",Compounding Pharmacy/Adulterated Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharma-700962-04022025,700962.0,2025,0,0
555,04/02/2025,"Empower Clinic Services, LLC dba Empower Pharmacy",Compounding Pharmacy/Adulterated Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharmacy-700964-04022025,700964.0,2025,0,0
556,04/02/2025,"Taizhou Jingshang Cosmetics Technology Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/taizhou-jingshang-cosmetics-technology-co-ltd-701945-04022025,701945.0,2025,0,0
557,04/01/2025,NWL Netherlands Services B.V.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nwl-netherlands-services-bv-701206-04012025,701206.0,2025,0,0
558,03/30/2022,kubapharm.com,Unlawful Sale of Schedule II Stimulants to Consumers over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kubapharmcom-622051-03302022,622051.0,2022,0,0
559,03/30/2022,premiumlightsupplier.com,Unlawful Sale of Schedule II Stimulants to Consumers over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/premiumlightsuppliercom-622056-03302022,622056.0,2022,0,0
560,03/28/2025,"Prodose, Inc. formerly known as Spirit Pharmaceuticals LLC",Electronic Drug Registration and Listing System (eDRLS)/Violations,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/prodose-inc-formerly-known-spirit-pharmaceuticals-llc-654751-03282025,654751.0,2025,0,0
562,03/28/2022,CBD Social,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cbd-social-627044-03282022,627044.0,2022,0,0
564,03/28/2022,Greenway Herbal Products LLC,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/greenway-herbal-products-llc-627042-03282022,627042.0,2022,0,0
565,03/28/2022,Cureganics,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cureganics-627288-03282022,627288.0,2022,0,0
566,03/28/2022,Nature's Highway,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/natures-highway-627304-03282022,627304.0,2022,0,0
568,03/28/2022,Heaven’s Organic LLC,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/heavens-organic-llc-627359-03282022,627359.0,2022,0,0
569,03/27/2025,www.thesafepills.org,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwthesafepillsorg-702942-03272025,702942.0,2025,0,0
570,03/27/2025,Yiling Pharmaceutical Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/yiling-pharmaceutical-ltd-699738-03272025,699738.0,2025,0,0
571,03/27/2024,Bodywell Natural Skin Care Inc.,CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bodywell-natural-skin-care-inc-677099-03272024,677099.0,2024,0,0
572,03/26/2025,Naturista Store LLC,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/naturista-store-llc-701480-03262025,701480.0,2025,0,0
574,03/25/2025,BioAsia Worldwide Sdn Bhd,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bioasia-worldwide-sdn-bhd-700093-03252025,700093.0,2025,0,0
576,03/25/2024,Tattoo Numbing Cream Co.,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tattoo-numbing-cream-co-672467-03252024,672467.0,2024,0,0
577,03/25/2024,"Dermal Source, Inc.",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dermal-source-inc-663632-03252024,663632.0,2024,0,0
578,03/25/2024,"SeeNext Venture, Ltd.",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/seenext-venture-ltd-674915-03252024,674915.0,2024,0,0
579,03/25/2024,TKTX Company,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tktx-company-673879-03252024,673879.0,2024,0,0
580,03/25/2024,Indelicare DBA INKEEZE,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/indelicare-dba-inkeeze-671656-03252024,671656.0,2024,0,0
581,03/25/2022,Iodine Products Inc,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/iodine-products-inc-628296-03252022,628296.0,2022,0,0
582,03/24/2025,"Huangshi Hygienic Material Medicine Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/huangshi-hygienic-material-medicine-co-ltd-700658-03242025,700658.0,2025,0,0
583,03/24/2022,Applied Biological Laboratories Inc.,Unapproved and Misbranded Product Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/biolab-sciences-inc-621465-08232022,621465.0,2022,0,0
584,03/22/2024,Antaria Pty. Ltd.,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/antaria-pty-ltd-674495-03222024,674495.0,2024,0,0
585,03/22/2023,"Tyrone L. McCall, M.D./Cornea Associates of Texas",Clinical Investigator (Sponsor) ,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tyrone-l-mccall-mdcornea-associates-texas-651261-03222023,651261.0,2023,0,0
586,03/21/2024,"Bret R. Rutherford, M.D.",Clinical Investigator (Sponsor) ,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bret-r-rutherford-md-670544-03212024,670544.0,2024,0,0
587,03/21/2024,New York State Psychiatric Institute IRB,Institutional Review Board (IRB),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/new-york-state-psychiatric-institute-irb-670989-03212024,670989.0,2024,0,0
589,03/20/2025,"BPI Labs, LLC",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bpi-labs-llc-699533-03202025,699533.0,2025,0,0
590,03/19/2024,Ammonia Sport Inc.,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ammonia-sport-inc-672196-03192024,672196.0,2024,0,0
591,03/18/2024,"Deqing Jiarou Daily Chemical Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/deqing-jiarou-daily-chemical-co-ltd-677928-03182024,677928.0,2024,0,0
592,03/16/2023,www.ivermectin4covid.com,Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwivermectin4covidcom-650184-03162023,650184.0,2023,0,0
593,03/15/2022,"Iotech International, LLC",Unapproved New Drug and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/iotech-international-llc-617715-03152022,617715.0,2022,0,0
595,03/14/2023,Procter & Gamble Manufactura S. de R.L. de C.V.,Failure to Register and List,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/procter-gamble-manufactura-s-de-rl-de-cv-650837-03142023,650837.0,2023,0,0
596,03/14/2023,"Robert J. Hayashi, M.D./Washington University School of Medicine, Department of Pediatrics",Bioresearch Monitoring Program/IRB,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/robert-j-hayashi-mdwashington-university-school-medicine-department-pediatrics-654873-03142023,654873.0,2023,0,0
597,03/14/2022,Dr Retter Ec Wladyslaw Retter,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dr-retter-ec-wladyslaw-retter-619881-03142022,619881.0,2022,0,0
598,03/13/2024,Skull Smash LLC,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/skull-smash-llc-672714-03132024,672714.0,2024,0,0
599,03/12/2025,Kabana Skin Care,Unapproved New Drugs/Misbranded/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kabana-skin-care-688254-03122025,688254.0,2025,0,0
600,03/12/2025,CoLabs Intl. Corp,Unapproved New Drugs/Misbranded/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/colabs-intl-corp-688285-03122025,688285.0,2025,0,0
601,03/12/2025,Neva Global Grup Sanayi Ic Ve Dis Ticaret Anonim Sirketi,CGMP/Finished Pharmaceutical/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/neva-global-grup-sanayi-ic-ve-dis-ticaret-anonim-sirketi-699000-03122025,699000.0,2025,0,0
602,03/12/2025,Waxhead Sun Defense Company,OTC/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/waxhead-sun-defense-company-688286-03122025,688286.0,2025,0,0
603,03/12/2025,"Yangzhou Sion Commodity Co., Ltd.",CGMP/Finished Pharmaceutical/API/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/yangzhou-sion-commodity-co-ltd-699183-03122025,699183.0,2025,0,0
604,03/10/2025,International Laboratories Corp,CGMP/Finished Pharmaceutical/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/international-laboratories-corp-698522-03102025,698522.0,2025,0,0
605,03/10/2022,Soda Pharm,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/soda-pharm-626261-03102022,626261.0,2022,0,0
606,03/08/2024,"Spirochaete Research Labs, LLC aka Scitus Laboratory Products",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/spirochaete-research-labs-llc-aka-scitus-laboratory-products-674278-03082024,674278.0,2024,0,0
607,03/07/2022,"Viraldine, LLC",Unapproved New Drug Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/viraldine-llc-625675-03072022,625675.0,2022,0,0
608,03/06/2025,Pico IV Inc.,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pico-iv-inc-700591-03062025,700591.0,2025,0,0
609,03/05/2025,"Mehran Michael Bahrami, M.D.",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mehran-michael-bahrami-md-703689-03052025,703689.0,2025,0,0
610,03/05/2025,Macsen Drugs,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/macsen-drugs-698202-03052025,698202.0,2025,0,0
611,03/05/2025,"Annovex Pharma, Inc.",Compounding Pharmacy/Adulterated Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/annovex-pharma-inc-698115-03052025,698115.0,2025,0,0
612,03/05/2025,Aspen Biopharma Labs Private Limited,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aspen-biopharma-labs-private-limited-698665-03052025,698665.0,2025,0,0
613,03/04/2025,C & A Naturistics,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/c-naturistics-693439-03042025,693439.0,2025,0,0
614,03/04/2025,"ProRx, LLC",Compounding Pharmacy/Adulterated Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/prorx-llc-696742-03042025,696742.0,2025,0,0
615,03/03/2025,Filler Lux dba Filler Lux USA,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/filler-lux-dba-filler-lux-usa-699221-03032025,699221.0,2025,0,0
616,03/03/2025,Fox Pharma LLC,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fox-pharma-llc-699225-03032025,699225.0,2025,0,0
617,03/03/2025,"Hyaluron Pen Store, LLC dba Glow Nest Beauty",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hyaluron-pen-store-llc-dba-glow-nest-beauty-700256-03032025,700256.0,2025,0,0
618,03/03/2025,Julian Naya Beauty LLC,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/julian-naya-beauty-llc-699782-03032025,699782.0,2025,0,0
619,03/03/2025,Vivid-Scientific LLC,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/vivid-scientific-llc-699226-03032025,699226.0,2025,0,0
620,03/03/2025,"Amazon.com, Inc.",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazoncom-inc-629452-08042022,629452.0,2025,1,0
621,03/03/2023,"Maggie Jeffries, M.D. / Avanti Anesthesiology, LLC",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maggie-jeffries-md-avanti-anesthesiology-llc-646498-03032023,646498.0,2023,0,0
622,03/02/2023,"ElectRx and Health Solutions, LLC",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/electrx-and-health-solutions-llc-614251-03022023,614251.0,2023,0,0
623,03/01/2021,"Ageless Global, LLC",Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ageless-global-llc-612865-03012021,612865.0,2021,0,0
624,03/01/2021,Marco Antonio Rodriguez Fierro,Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/marco-antonio-rodriguez-fierro-610110-03012021,610110.0,2021,0,0
625,03/01/2021,Gaza Proveedora De Servicios De Hospedaje Y Alimentacion,Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/gaza-proveedora-de-servicios-de-hospedaje-y-alimentacion-611881-03012021,611881.0,2021,0,0
627,02/28/2025,Shree Jaya Laboratories PVT. LTD.,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/shree-jaya-laboratories-pvt-ltd-698690-02282025,698690.0,2025,0,0
628,02/28/2024,Native Salts LLC,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/native-salts-llc-674277-02282024,674277.0,2024,0,0
629,02/28/2022,"Sabine S. Hazan, M.D.",Clinical Investigator (CI),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sabine-s-hazan-md-628110-02282022,628110.0,2022,0,0
630,02/27/2024,"Thai Nakorn Patana Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/thai-nakorn-patana-co-ltd-672712-02272024,672712.0,2024,0,0
631,02/26/2025,Granules India Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/granules-india-limited-697115-02262025,697115.0,2025,0,0
632,02/26/2025,USApeptide.com,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/usapeptidecom-696885-02262025,696885.0,2025,0,0
633,02/25/2025,TKTX USA,Unapproved New Drugs/Misbranded/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tktx-usa-698435-02252025,698435.0,2025,0,0
634,02/25/2025,TKTX Numb Store,Unapproved New Drug and Misbranded/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tktx-numb-store-697051-02252025,697051.0,2025,0,0
635,02/25/2025,TKTX Store,Unapproved New Drugs/Misbranded/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tktx-store-698371-02252025,698371.0,2025,0,0
636,02/25/2025,TKTX Numbing Cream USA,Unapproved New Drugs/Misbranded/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tktx-numbing-cream-usa-702106-02252025,702106.0,2025,0,0
637,02/25/2025,"Linghai ZhanWang Biotechnology Co., Ltd",CGMP/Finished Pharmaceutical/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/linghai-zhanwang-biotechnology-co-ltd-697983-02252025,697983.0,2025,0,0
638,02/25/2022,Ivermectin24h.com,Unlawful Sale of Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ivermectin24hcom-615637-02252022,615637.0,2022,0,0
639,02/25/2021,Inovaker Lab S.A. de C.V.,Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/inovaker-lab-sa-de-cv-609979-02252021,609979.0,2021,0,0
640,02/24/2025,Aspen Pharmacare Holdings Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aspen-pharmacare-holdings-limited-701671-02242025,701671.0,2025,0,0
641,02/22/2024,"Innovative Formulations, LLC dba Insane Labz",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/innovative-formulations-llc-dba-insane-labz-672952-02222024,672952.0,2024,0,0
642,02/22/2022,My Natural Treatment,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/my-natural-treatment-624734-02222022,624734.0,2022,0,0
643,02/22/2021,Yara Elena De La Garza Perez Nieto,Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/yara-elena-de-la-garza-perez-nieto-608697-02222021,608697.0,2021,0,0
645,02/18/2021,Absara Cosmetics S.A.P.I DE C.V.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/absara-cosmetics-sapi-de-cv-612455-02182021,612455.0,2021,0,0
646,02/16/2021,Dr. Paul's Lab,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dr-pauls-lab-612964-02162021,612964.0,2021,0,0
648,02/15/2024,LightEyez Limited,CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lighteyez-limited-665450-02152024,665450.0,2024,0,0
649,02/15/2022,rxshopmd.com,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/rxshopmdcom-615753-02152022,615753.0,2022,0,0
650,02/15/2022,Extrapharmacy.ru,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/extrapharmacyru-615132-02152022,615132.0,2022,0,0
651,02/14/2024,Amman Pharmaceutical Industries,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amman-pharmaceutical-industries-668867-02142024,668867.0,2024,0,0
652,02/13/2025,Zenzi Pharmaceutical Industries Pvt. Ltd.,Refusal to Provide Access to and Copying of Records,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zenzi-pharmaceutical-industries-pvt-ltd-701130-02132025,701130.0,2025,0,0
653,02/13/2024,Salvacion USA Inc.,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/salvacion-usa-inc-672252-02132024,672252.0,2024,0,0
654,02/13/2023,Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/delta-kozmetik-sanayi-ve-ticaret-selim-yesil-645478-02132023,645478.0,2023,0,0
655,02/11/2025,"Chem-Tech, Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/chem-tech-ltd-696920-02112025,696920.0,2025,0,0
657,02/10/2025,Marshalls Traditional Healthcare CC,CGMP/Finished Pharmaceutical/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/marshalls-traditional-healthcare-cc-697697-02102025,697697.0,2025,0,0
658,02/10/2025,ABR Laboratory LLC,CGMP/Finished Pharmaceutical/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/abr-laboratory-llc-696872-02102025,696872.0,2025,0,0
659,02/09/2024,ivsupplyclinic.com,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ivsupplycliniccom-672780-02092024,672780.0,2024,0,0
660,02/07/2024,US Chem Labs,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/us-chem-labs-669074-02072024,669074.0,2024,0,0
661,02/07/2024,Synthetix Inc. DBA Helix Chemical Supply,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/synthetix-inc-dba-helix-chemical-supply-668918-02072024,668918.0,2024,0,0
662,02/06/2025,Tyche Industries Ltd,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tyche-industries-ltd-693081-02062025,693081.0,2025,0,0
663,02/06/2024,Global Life Technologies Corp.,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/global-life-technologies-corp-674279-02062024,674279.0,2024,0,0
664,02/06/2023,"The Body Bean, LLC",Failure to Register and List,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/body-bean-llc-649817-02062023,649817.0,2023,0,0
665,02/05/2025,"Chengdu Innovation Pharmaceutical Co., Ltd.",CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/chengdu-innovation-pharmaceutical-co-ltd-698786-02052025,698786.0,2025,0,0
666,02/05/2025,Jagsonpal Pharmaceuticals Limited,CGMP/Finished Pharmaceutical/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/jagsonpal-pharmaceuticals-limited-693134-02052025,693134.0,2025,0,0
667,02/05/2024,Ningbo Poplar Daily-Use,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ningbo-poplar-daily-use-669486-02052024,669486.0,2024,0,0
668,02/05/2024,Sichuan Deebio Pharmaceutical Co. Ltd.,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sichuan-deebio-pharmaceutical-co-ltd-669808-02052024,669808.0,2024,0,0
670,02/04/2025,"Wuhu Nuowei Chemistry Co., Ltd.",CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wuhu-nuowei-chemistry-co-ltd-697727-02042025,697727.0,2025,0,0
671,02/04/2025,"ISOThrive, Inc.",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/isothrive-inc-688547-02042025,688547.0,2025,0,0
672,02/04/2022,Crystal Clear Supplements,Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/crystal-clear-supplements-620285-02042022,620285.0,2022,0,0
673,02/04/2022,"Richard J. Obiso, PhD dba Avila Herbals, LLC",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/richard-j-obiso-phd-dba-avila-herbals-llc-622821-02042022,622821.0,2022,0,0
674,02/03/2022,"ECI Pharmaceuticals, LLC",Failure to Register and List,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eci-pharmaceuticals-llc-625254-02032022,625254.0,2022,1,0
675,02/03/2022,Pharmacy2Home/LandiCom Holding LTD,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pharmacy2homelandicom-holding-ltd-615137-02032022,615137.0,2022,0,0
676,02/03/2022,"ECI Pharmaceuticals, LLC",Failure to Register and List,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eci-pharmaceuticals-llc-625254-02032022,625254.0,2022,1,0
677,02/03/2021,"ShangRao Chunyu Technology Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/shangrao-chunyu-technology-co-ltd-610194-02032021,610194.0,2021,0,0
678,02/03/2021,"AAA Cosmetica, SA de CV",Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aaa-cosmetica-sa-de-cv-609083-02032021,609083.0,2021,0,0
680,02/02/2024,"Ehy Holdings, LLC",Failure to Register and List,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ehy-holdings-llc-675591-02022024,675591.0,2024,0,0
681,02/02/2022,Indiana Chem-Port,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/indiana-chem-port-618173-02022022,618173.0,2022,0,0
682,02/01/2024,Madhu Instruments Private Limited,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/madhu-instruments-private-limited-659694-02012024,659694.0,2024,0,0
684,01/31/2024,Les Importations Herbasanté Inc.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/les-importations-herbasante-inc-668412-01312024,668412.0,2024,0,0
685,01/30/2025,Strukmyer LLC dba Strukmyer Medical,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/strukmyer-llc-dba-strukmyer-medical-692686-01302025,692686.0,2025,0,0
686,01/30/2023,Fei Fah Medical Manufacturing Pte. Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fei-fah-medical-manufacturing-pte-ltd-633084-01302023,633084.0,2023,0,0
687,01/30/2023,"Old Tiles Wallpaper, LLC DBA Old Tiles Decor",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/old-tiles-wallpaper-llc-dba-old-tiles-decor-643920-01302023,643920.0,2023,0,0
688,01/30/2023,Monkeypox-treatment.com,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/monkeypox-treatmentcom-644773-01302023,644773.0,2023,0,0
689,01/29/2025,"AmWiner & Raphe Holdings, LLC  dba rapheGenerics Corp",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amwiner-raphe-holdings-llc-dba-raphegenerics-corp-698782-01292025,698782.0,2025,0,0
690,01/29/2021,"Ignacio J. Rodriguez, MD",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ignacio-j-rodriguez-md-613002-01292021,613002.0,2021,0,0
691,01/28/2025,Rite-Kem Incorporated,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/rite-kem-incorporated-697272-01282025,697272.0,2025,0,0
692,01/28/2025,"Shantou Kangjie Daily Chemical Industry Co., Ltd",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/shantou-kangjie-daily-chemical-industry-co-ltd-698223-01282025,698223.0,2025,0,0
693,01/28/2021,rx2go.com,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/rx2gocom-612391-01282021,612391.0,2021,0,0
694,01/28/2021,sandra-pharma.is,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sandra-pharmais-611909-01282021,611909.0,2021,0,0
695,01/28/2021,buy-pharma.md,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/buy-pharmamd-611907-01282021,611907.0,2021,0,0
696,01/28/2021,Simex Logistics S.A. de C.V.,Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/simex-logistics-sa-de-cv-610529-01282021,610529.0,2021,0,0
697,01/27/2025,"Imperial Palace Commodity -Dongguan- Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/imperial-palace-commodity-dongguan-co-ltd-692842-01272025,692842.0,2025,0,0
701,01/25/2021,"Grupo Plast-Y-Kosas, SA de CV",Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/grupo-plast-y-kosas-sa-de-cv-609493-01252021,609493.0,2021,0,0
702,01/25/2021,Ignacio Reyes Gonzalez,Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ignacio-reyes-gonzalez-609718-01252021,609718.0,2021,0,0
704,01/24/2024,Sambrosa Care Inc.,Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sambrosa-care-inc-673321-01242024,673321.0,2024,0,0
705,01/23/2025,Center for Instrumental Analysis of China Pharmaceutical University,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/center-instrumental-analysis-china-pharmaceutical-university-696906-01232025,696906.0,2025,0,0
706,01/22/2025,"Nubratori, Inc. dba Nubratori Rx",Compounding Pharmacy/Adulterated Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nubratori-inc-dba-nubratori-rx-700513-01222025,700513.0,2025,0,0
707,01/22/2024,"Mei Lan Thailand Co., Ltd.",CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/Refused Inspection,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mei-lan-thailand-co-ltd-672783-01222024,672783.0,2024,0,0
708,01/22/2021,"Yuyao YiJia Daily Chemical Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/yuyao-yijia-daily-chemical-co-ltd-610487-01222021,610487.0,2021,0,0
709,01/21/2025,Kardesler Ucan Yaglar Sanayi Anonim Sirketi,CGMP/Finished Pharmaceutical/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kardesler-ucan-yaglar-sanayi-anonim-sirketi-695413-01212025,695413.0,2025,0,0
710,01/18/2023,"Buzzagogo, LLC",CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/buzzagogo-llc-639545-01182023,639545.0,2023,0,0
711,01/18/2022,CES LLC,Drug Product/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ces-llc-623495-01182022,623495.0,2022,0,0
713,01/16/2025,Global Calcium Pvt. Limited,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/global-calcium-pvt-limited-692000-01162025,692000.0,2025,0,0
714,01/16/2024,"Glicerinas Industriales, S.A. de C.V.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glicerinas-industriales-sa-de-cv-665472-01162024,665472.0,2024,1,0
715,01/15/2025,Sanofi,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sanofi-690604-01152025,690604.0,2025,0,0
716,01/13/2025,www.weightcrunchshop.com,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwweightcrunchshopcom-695815-01132025,695815.0,2025,0,0
717,01/12/2022,Aurobindo Pharmaceutical Limited,CGMP/Active Pharmaceutical Ingredient (API)/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aurobindo-pharmaceutical-limited-618091-01122022,618091.0,2022,0,0
718,01/11/2023,Larkin Community Hospital Institutional Review Board,Bioresearch Monitoring Program/Institutional Review Board (IRB),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/larkin-community-hospital-institutional-review-board-638146-01112023,638146.0,2023,0,0
719,01/10/2023,"Medical Mikes, Inc.",Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medical-mikes-inc-647603-01102023,647603.0,2023,0,0
720,01/10/2023,Purecraft LLC,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/purecraft-llc-648077-01102023,648077.0,2023,0,0
721,01/10/2023,"HIS Enterprise Inc dba Adam’s Secret USA, LLC",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/his-enterprise-inc-dba-adams-secret-usa-llc-646494-01102023,646494.0,2023,0,0
722,01/09/2023,"Distributor RFR, LLC",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/distributor-rfr-llc-643724-01092023,643724.0,2023,0,0
723,01/08/2025,"Atlanta Supersource, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/atlanta-supersource-inc-693399-01082025,693399.0,2025,0,0
724,01/06/2023,pharmahealthonline.com,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pharmahealthonlinecom-648510-01062023,648510.0,2023,0,0
725,01/06/2022,"Cosmo Bio Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cosmo-bio-co-ltd-611552-01062022,611552.0,2022,0,0
726,01/05/2023,PharmaCanna,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pharmacanna-647390-01052023,647390.0,2023,0,0
727,01/04/2021,Coco's Holistic Specialties & Apothecary,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cocos-holistic-specialties-apothecary-612001-01042021,612001.0,2021,0,0
728,01/03/2022,"Amcyte Pharma, Inc.",Unapproved and Misbranded Product Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amcyte-pharma-inc-623474-01032022,623474.0,2022,0,0
36,12/12/2025,"Maria A. Carballosa, M.D.",In Vivo Bioavailability-Bioequivalence Studies – Clinical,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maria-carballosa-md-720805-12122025,720805.0,2025,0,0
82,11/16/2023,"Discover Health, LLC d/b/a Discover CBD and Strain Snobs",Finished Pharmaceuticals/Unapproved New Drugs/Animal Drugs/Human Foods/Animal Foods/Adulterated/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/discover-health-llc-dba-discover-cbd-and-strain-snobs-661488-11162023,661488.0,2023,0,0
91,11/13/2025,Save Rite Medical,Nonprescription/OTC,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/save-rite-medical-717838-11132025,717838.0,2025,0,0
99,11/12/2024,"Zhejiang Uniquality Nursing Products Technology Co., Ltd. dba ZheJiang YouQuan Care Products Technology Co., Ltd.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zhejiang-huahai-pharmaceutical-co-ltd-707145-06062025,707145.0,2024,0,0
112,11/04/2021,Bionateo Sp. z.o.o.,CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bionateo-sp-zoo-614651-11042021,614651.0,2021,0,0
135,10/30/2025,"Owen Biosciences, Inc.",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/owen-biosciences-inc-710275-10302025,710275.0,2025,0,0
324,08/25/2025,Mel Honey US,Unapproved New Drugs/Ophthalmic Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mel-honey-us-709535-08252025,709535.0,2025,0,0
325,08/25/2025,Supply Center USA,Unapproved New Drugs/Ophthalmic Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/supply-center-usa-710859-08252025,710859.0,2025,0,0
326,08/25/2025,Trew Balance,Unapproved New Drugs/Ophthalmic Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/trew-balance-709880-08252025,709880.0,2025,0,0
327,08/25/2025,Life Enthusiast Co-op,Unapproved New Drugs/Ophthalmic Drug Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/life-enthusiast-co-op-709315-08252025,709315.0,2025,0,0
328,08/23/2023,Green Pharmaceutical Co. Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/green-pharmaceutical-co-ltd-663544-08232023,663544.0,2023,0,0
329,08/22/2025,"Wisconsin Pharmacal Company, LLC",CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wisconsin-pharmacal-company-llc-710329-08222025,710329.0,2025,0,0
330,08/20/2025,Chromatography Institute of America dba Compounder’s International Analytical Laboratory,CGMP/Finished Pharmaceutical/API/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/chromatography-institute-america-dba-compounders-international-analytical-laboratory-708944-08202025,708944.0,2025,0,0
336,08/18/2023,"Amazon.com, Inc",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazoncom-inc-662503-12202023,662503.0,2023,0,0
340,08/18/2023,"Thrasio, LLC D/B/A ZymaDerm",Unapproved New Drugs/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/thrasio-llc-dba-zymaderm-649788-08182023,649788.0,2023,0,0
352,08/08/2023,International Laboratories Corp. Ltd.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/international-laboratories-corp-ltd-664352-08082023,664352.0,2023,0,0
428,06/30/2022,Omni Consumer Products LLC d/b/a YoKratom,Finished Pharmaceuticals/Unapproved New Drug,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/omni-consumer-products-llc-dba-yokratom-634184-06302022,634184.0,2022,0,0
432,06/27/2022,DDI Multinacional S.A. de C.V.,Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ddi-multinacional-sa-de-cv-608864-06272022,608864.0,2022,0,0
433,06/27/2022,"Noticias Mexico Hoy Grupo Multimedia, S.A. de C.V.",Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/noticias-mexico-hoy-grupo-multimedia-sa-de-cv-609658-06272022,609658.0,2022,0,0
434,06/26/2025,"Mark J. Savant, M.D",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mark-j-savant-md-712306-06262025,712306.0,2025,0,0
455,06/13/2022,"Glicerinas Industriales, S.A. de C.V.",CGMP/Finished Drug Products/Refusal/Limited Inspection,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glicerinas-industriales-sa-de-cv-665472-01162024,665472.0,2022,1,0
477,05/23/2022,Grimann S.A. de C.V.,Failure to Comply with Drug Registration and Listing Requirements,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/grimann-sa-de-cv-632272-05232022,632272.0,2022,0,0
492,05/05/2025,www.buycodeine.us,Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwbuycodeineus-702527-05052025,702527.0,2025,0,0
500,05/04/2022,Delta 8 Hemp,Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/delta-8-hemp-618368-05042022,618368.0,2022,0,0
546,04/06/2023,Zermat International S.A. de C.V.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zermat-international-sa-de-cv-647232-04062023,647232.0,2023,0,0
561,03/28/2024,Kilitch Healthcare India Limited,CGMP/Finished Pharmaceutical/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kilitch-healthcare-india-limited-672956-03282024,672956.0,2024,0,0
567,03/28/2022,UPSY LLC,Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19),https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/upsy-llc-627962-03282022,627962.0,2022,0,0
573,03/25/2025,"Americo F. Padilla, M.D.",Clinical Investigator,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/americo-f-padilla-md-700447-03252025,700447.0,2025,0,0
575,03/25/2024,"Sky Bank Media, LLC dba Painless Tattoo Cream Co.",Finished Pharmaceuticals/Unapproved New Drug/Misbranded,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sky-bank-media-llc-dba-painless-tattoo-cream-co-666693-03252024,666693.0,2024,0,0
588,03/21/2024,Betone S.A. de C.V.,CGMP/Finished Pharmaceuticals/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/betone-sa-de-cv-674299-03212024,674299.0,2024,0,0
594,03/14/2025,Advanced Pharmaceutical Technology,CGMP/Finished Pharmaceutical/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/advanced-pharmaceutical-technology-692576-03142025,692576.0,2025,0,0
656,02/11/2021,"Evolved Ayurvedic Discoveries, Inc./BioCBDPlus",Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated,https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/evolved-ayurvedic-discoveries-incbiocbdplus-609772-02112021,609772.0,2021,0,0
